Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid-based biopsies of thyroid neoplasms suspicious for carcinoma

European Journal of Endocrinology

Volumn 168, Issue 6, 2013, Pages 853-859

  Rossi, Esther Diana ^a   Martini, Maurizio ^a   Capodimonti, Sara ^a   Straccia, Patrizia ^a   Cenci, Tonia ^a   Lombardi, Celestino Pio ^a   Pontecorvi, Alfredo ^a   Larocca, Luigi Maria ^a   Fadda, Guido ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MOLECULAR MARKER;

ADULT; AGED; ARTICLE; BRAF GENE; CORRELATION ANALYSIS; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE ACTIVITY; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; HISTOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; LIQUID BASE CYTOLOGY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA;

CARCINOMA; DNA MUTATIONAL ANALYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS;

EID: 84878735460     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0023     Document Type: Article

References (45)

1. Fadda G & Rossi ED. Liquid based cytology in fine-needle aspiration biopsies of the thyroid gland. Acta Cytologica 2011 55 389-400. (doi:10.1159/000329029)
2. Rossi ED, Raffaelli M, Minimo C, Mule A, Lombardi CP, Vecchio FM & Fadda G. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies. Cancer 2005 105 87-95. (doi:10.1002/cncr.21026) (Pubitemid 40604942)
3. Cochand-Priollet B, Prat JJ, Polivka M, Thienpont L, Dahan H, Wassef M & Guillausseau PJ. Thyroid fine needle aspiration: the morphological features on ThinPrep slide preparations. Eighty cases with histological control. Cytopathology 2003 14 343-349. (doi:10.1046/j.0956-5507.2003.00098.x) (Pubitemid 37521866)
4. Fadda G, Basolo F, Bondi A, Bussolati G, Crescenzi A, Nappi O, Nardi F, Papotti M, Taddei G, Palombini L et al. Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian consensus working group. Pathologica 2010 102 405-408.
5. Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Poté N, Sarfati E et al. Immunocytochemistry with cytokeratin 19 and HBME-1 increases the diagnostic accuracy of thyroid fine-needle aspirations. Preliminary report of 150 liquid-based fine needle aspirations with histological control. Thyroid 2011 21 1067-1073. (doi:10.1089/thy.2011.0014)
6. Cheung CC, Ezzat S, Freeman JL, Rosen IB & Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Modern Pathology 2001 14 338-342. (doi:10.1038/modpathol.3880312) (Pubitemid 32298919)
7. Herrmann ME, LiVolsi VA, Pasha TL, Roberts SA, Wojcik EM & Baloch ZW. Immunohistochemical expression of Galectin-3 in benign and malignant thyroid lesions. Archives of Pathology & Laboratory Medicine 2002 126 710-713. (Pubitemid 34602574)
8. Dabbs D, Abendroth CS, Grenko RT, Wang X & Gail ER. Immunocytochemistry on the Thin-Prep Processor. Diagnostic Cytopathology 1997 17 388-392. (doi:10.1002/(SICI)1097-0339(199711)17:5<388::AID-DC14O3.0.CO;2-J)
9. Nikiforova MN & Nikiforov Y. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009 19 1351-1361. (doi:10.1089/thy.2009.0240)
10. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K & Nikiforova MN. Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. Journal of Clinical Endocrinology and Metabolism 2009 94 2092-2098. (doi:10.1210/jc.2009-0247)
11. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R & Sobrinho-Simões M. BRAF mutations and RET/PTC rearrangements are alternative events in the ethiopathogenesis of PTC. Oncogene 2003 22 4578-4580. (doi:10.1038/sj.onc.1206706) (Pubitemid 36920701)
12. Cheung CC, Carydis B, Ezzat S, Bedard YC & Asa SL. Analysis of RET/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2001 86 2187-2190. (doi:10.1210/jc.86.5.2187) (Pubitemid 32472938)
13. Puxeddu E, Durante C, Avenia N, Filetti S & Russo D. Clinical implications of BRAF mutation in thyroid carcinoma. Trends in Endocrinology and Metabolism 2008 19 138-145. (doi:10.1016/j.tem.2007.12.003) (Pubitemid 351621952)
14. Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L & Nikiforov YE. Contribution of molecular testing to thyroid fine needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance". Cancer Cytopathology 2010 118 17-23. (doi:10.1002/cncy.20063)
15. Tulecke MA & Wang HH. ThinPrep for cytologic evaluation of follicular thyroid lesions: correlation with histologic findings. Diagnostic Cytopathology 2003 30 7-13. (doi:10.1002/dc.10391)
16. Scurry JP & Duggan MA. Thin layer compared to direct smear in thyroid fine-needle aspiration. Cytopathology 2000 11 104-115. (doi:10.1046/j.1365- 2303.2000.00228.x) (Pubitemid 30216816)
17. Afify AM, Liu J & Al-Khafaji BM. Cytologic artefacts and pitfalls of thyroid fine needle aspiration using Thin Prep. Cancer Cytopathology 2001 93 179-186.
18. Malle D, Valeri RM, Pazaitou-Panajiotou K, Kiziridou A, Vainas I & Destouni C. Use of thin layer technique in thyroid fine needle aspiration. Acta Cytologica 2006 50 23-27. (doi:10.1159/000325890) (Pubitemid 43157427)
19. Ravetto C, Colombo L & Dottorini ME. Usefulness of fineneedle aspiration in the diagnosis of thyroid carcinomas. A retrospective study in 37,895 patients. Cancer Cytopathology 2000 90 357-363. (Pubitemid 32011847)
20. Poller DN, Ibrahim AK, Cummings MH, Mikel JJ, Boote D & Perry M. Fine-needle aspiration of the thyroid. Importance of an indeterminate diagnostic category. Cancer Cytopathology 2000 90 239-244. (Pubitemid 30660112)
21. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK & Frable WJ. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute fine-needle aspiration state-of-science conference. Diagnostic Cytopathology 2008 36 425-437. (doi:10.1002/dc.20830) (Pubitemid 351829800)
22. Fadda G, Rossi ED, Raffaelli M, Mulè A, Pontecorvi A, Miraglia A, Lombardi CP & Vecchio FM. Fine-needle aspiration biopsy of thyroid lesions processed by thin-layer cytology: one-year institutional experience with histologic correlation. Thyroid 2006 16 975-981. (doi:10.1089/thy.2006.16.975) (Pubitemid 46141298)
23. Saleh HA, Hammoud J, Zakaria R & Khan AZ. Comparison of Thin-Prep and cell block preparation for the evaluation of thyroid epithelial lesions on fine needle aspiration biopsy. CytoJournal 2008 5 3. (doi:10.1186/1742-6413-5-3) (Pubitemid 351519242)
24. British Thyroid Association, Royal College of Physicians. Guidelines for the management of thyroid cancer Ed. P Perros 2nd edition. Report of the Thyroid Cancer Guidelines Update Group. London: Royal College of Physicians, 2007.
25. Cibas ES & Ali SZ. The Bethesda system for reporting thyroid cytopathology. American Journal of Clinical Pathology 2009 132 658-665. (doi:10.1309/AJCPPHLWMI3JV4LA)
26. Martini M, Teofili L, Cenci T, Giona F, Torti L, Rea M, Foà R, Leone G & Larocca LM. A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis. Haematologia 2008 93 1068-1071. (doi:10.3324/haematol.13210) (Pubitemid 351957024)
27. Faquin WC & Baloch ZW. Fine needle aspiration of follicular patterned lesions of the thyroid. Diagnosis, management and follow-up according to national cancer institute (NCI) recommendations. Diagnostic Cytopathology 2010 38 731-739. (doi:10.1002/dc.21292)
28. Mahajan A, Lin X & Nayar R. Thyroid Bethesda reporting category, suspicious for papillary thyroid carcinoma, pitfalls and clues to optimize the use of this category. Cytopathology 2013 24 85-91. (doi:10.1111/j.1365-2303. 2012.00966.x)
29. Fadda G, Rossi ED, Raffaelli M, Pontecorvi A, Sioletic S, Morassi F, Lombardi CP, Zannoni GF & Rindi G. Follicular thyroid neoplasms can be classified as low and high risk according to HBME-1 and Galectine 3 expression on liquid based fine needle cytology. European Journal of Endocrinology 2011 165 447-453. (doi:10.1530/EJE-11-0181)
30. Correia-Rodrigues HG, Nogueira De Pontes AA & Adan LFF. Use of molecular markers in samples obtained from preoperative aspiration of thyroid. Endocrine Journal 2012 59 417-424. (doi:10.1507/endocrj.EJ11-0410)
31. Chang H, Lee H, Yoon SO, Kim H, Kim A & Kim BH. BRAF (V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma. Human Pathology 2012 43 89-95. (doi:10.1016/j.humpath.2011.04.010)
32. Mathur A, Weng J & Moses W. A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsies. Surgery 2010 148 1176-1177. (doi:10.1016/j.surg.2010.09.025)
33. Niemeier LA, Kuffner Akatsu H, Song C, Carty SE, Hodak SP, Yip L, Ferris RL, Tseng GC, Seethala RR, Lebeau SO et al. A combined molecular-pathologic score improves risk stratification of papillary micro carcinoma. Cancer 2011 118 2069-2077. (doi:10.1002/cncr.26425)
34. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F et al. Revised management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009 19 1167-1214. (doi:10.1089/thy.2009.0110)
35. Yip L, Farris C, Kabaker AS, Hodak SP, Nikiforova MN, McCoy KL, Stang MT, Smith KJ, Nikiforov YE & Carty SE. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. Journal of Clinical Endocrinology and Metabolism 2012 07 1905-1912. (doi:10.1210/jc.2011- 3048)
36. Cisco RM, Shen WT & Gosnell JE. Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection. Current Treatment Options in Oncology 2010 13 1-10. (doi:10.1007/s11864-011-0175-z)
37. Xing M. Braf mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocrine Reviews 2007 28 742-762. (doi:10.1210/er.2007-0007) (Pubitemid 350294294)
38. Oler G, Camacho CP, Hojaij FC, Michaluart P Jr, Riggins GJ & Cerutti JM. Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis. Clinical Cancer Research 2008 14 4735-4742. (doi:10.1158/1078-0432.CCR-07-4372)
39. Musholt TJ, Fottner C, Weber M, Eichhorn W, Pohlenz J, Musholt PB, Springer E & Schad A. Detection of papillary carcinoma by analysis of BRAF and RET/PTC1 mutations in fine needle aspiration biopsies of thyroid nodules.World Journal of Surgery 2010 34 2595-2603. (doi:10.1007/s00268-010- 0729-4)
40. Park SY, Park YJ, Lee YJ, Lee HS, Choi SH, Choe G, Jang HC, Park SH, Park do J & Cho BY. Analysis of differential BRAF (V600E) mutational status in multifocal papillary thyroid carcinoma. Evidence of independent clonal origin in distinct tumor foci. Cancer 2006 107 1831-1838. (doi:10.1002/cncr.22218) (Pubitemid 44582952)
41. Eszlinger M & Paschke R. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Journal of Molecular and Cellular Endocrinology 2010 322 29-37. (doi:10.1016/j.mce.2010.01.010)
42. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH & Kebebew E. Molecular testing for somatic mutations improves the accuracy of thyroid fine needle aspiration biopsy. World Journal of Surgery 2010 34 2589-2594. (doi:10.1007/s00268-010-0720-0)
43. Rossi ED, Martini M, Capodimonti S, Lombardi CP, Pontecorvi A, Vellone VG, Zannoni GF, Larocca LM & Fadda G. BRAF (V600E) mutation analysis on LBC-processed aspiration biopsies predicts bilaterality and nodal involvement in papillary thyroid microcarcinoma. Cancer Cytopathology 2013. In press. (doi:10.1002/cncy.21258)
44. Schmitt F. Molecular cytopathology and flow cytometry: preanalytical procedures matter. Cytopathology 2011 22 355-357. (doi:10.1111/j.1365-2303.2011. 00941.x)
45. Schmitt FC, Longatto-Filho A, Valent A & Vielh P. Molecular techniques in cytopathology practice. Journal of Clinical Pathology 2008 61 258-267. (doi:10.1136/jcp.2006.044347) (Pubitemid 351354226)